Introduction: HCV coinfection studies at CROI

This annual conference is one of the most important annual scientific meetings.

Abstracts for the meeting are online as soon as the conference opens, and many of the most important oral abstract sessions and overview sessions are posted as webcasts within a day or so. We encourage readers to go directly to the source for many of these sessions:

http://www.retroconference.org

A non-technical summary of general news from the conference, covering 25 studies and presentations in 12 key areas, is available from the i-Base website.

While there were few studies relating to ARV4IDUs several studies on coinfection were interesting:

• MELD score predictive of pre-transplant mortality in HIV/HCV coinfected patients
• Does abacavir decrease SVR rates with HCV treatment?
• No effect of interferon maintenance therapy on fibrosis progression in non-responders